azomycin has been researched along with Melanoma in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (70.37) | 18.7374 |
| 1990's | 4 (14.81) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaustad, JV; Rofstad, EK; Simonsen, TG | 1 |
| Ellingsen, C; Galappathi, K; Mathiesen, B; Ovrebø, KM; Rofstad, EK | 1 |
| Kageyama, K; Kato, S; Kimura, M; Miwa, N; Tanaka, H | 1 |
| Brustad, T; Rofstad, EK | 3 |
| Agrawal, KC; Garg, PK; Larroquette, CA | 1 |
| Blekkenhorst, G; Cridland, S; Korrubel, J; Sealy, R | 1 |
| Adams, GE; Ahmed, I; Chaplin, DJ; Sheldon, PW | 1 |
| Curtis, S; Guichard, M; Malaise, EP; Tenforde, T | 1 |
| Clutterbuck, RD; McElwain, TJ; Millar, JL | 1 |
| Glatte, P; Haedecke, U; Osieka, R; Schmidt, CG | 1 |
| Gueulette, J; Guichard, M; Malaise, EP; Octave-Prignot, M; Wambersie, A | 1 |
| Denny, WA; Hay, MP; Lee, HH; Roberts, PB; Wilson, WR | 1 |
| el Gamoussi, R; Guichard, M; Stratford, IJ | 1 |
| el Gamoussi, R; Guichard, M; Prade, M; Stratford, IJ; Threadgill, MD | 1 |
| Galappathi, K; Graff, BA; Mathiesen, B; Nilsen, K; Rasmussen, H; Rofstad, EK | 1 |
| Peckham, MJ; Stanley, JA; Steel, GG | 1 |
| Munzenrider, JE | 1 |
| de Langen-Omri, F; Guichard, M; Malaise, EP | 1 |
| Guichard, ME; Lespinasse, F; Taghian, A | 1 |
| Dische, S | 1 |
| Bennett, MH; Dische, S; Orchard, R; Stratford, MR; Wardman, P | 1 |
| Chapman, JD; Kanclerz, A | 1 |
| Bleehen, NM; Newman, HF; Workman, P | 1 |
| Bennett, MH; Des Rochers, C; Dische, S; Dunphy, EP; Minchinton, AI; Saunders, MI; Stratford, MR; Wardman, P | 1 |
| Bleehen, NM; Newman, HF; Roberts, JT | 1 |
1 review(s) available for azomycin and Melanoma
| Article | Year |
|---|---|
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
26 other study(ies) available for azomycin and Melanoma
| Article | Year |
|---|---|
Development of hypoxia in a preclinical model of tumor micrometastases.
Topics: Animals; Blood Flow Velocity; Cell Hypoxia; Female; Humans; Melanoma; Mice; Mice, Inbred A; Mice, Nude; Nitroimidazoles; Rhodamines; Xenograft Model Antitumor Assays | 2010 |
pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Coloring Agents; Connective Tissue; Female; Humans; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Nitroimidazoles; Oxygen; Oxygen Consumption; Partial Pressure; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2012 |
Enhanced radiosensitization by liposome-encapsulated pimonidazole for anticancer effects on human melanoma cells.
Topics: Cell Line; Cell Survival; Humans; Liposomes; Materials Testing; Melanoma; Nanocapsules; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents | 2012 |
Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
Topics: Animals; Humans; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Prognosis; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1981 |
Pharmacokinetic studies of amino acid analogues of 2-nitroimidazole, new hypoxic cell radiosensitizers.
Topics: Amino Acids; Animals; Brain; Cell Survival; Cricetinae; Melanoma; Metabolic Clearance Rate; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Interstitial misonidazole. A preliminary report on a new perspective in clinical radiation sensitization and hypoxic cell chemotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Female; Humans; Injections; Male; Melanoma; Middle Aged; Misonidazole; Nitroimidazoles; Skin Neoplasms | 1984 |
Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1984 |
Effect of combined misonidazole and accelerated neon ions on a human melanoma transplanted into nude mice.
Topics: Animals; Cell Survival; Colony-Forming Units Assay; Female; Male; Melanoma; Mice; Mice, Nude; Misonidazole; Neon; Neoplasm Transplantation; Nitroimidazoles; Radiotherapy, High-Energy; Skin Neoplasms | 1982 |
Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carmustine; Cell Line; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Melphalan; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Transplantation, Heterologous | 1982 |
[Enhancement of MeCCNU potency (chemosensitization) by misonidazole in a human melanoma xenograft system].
Topics: Animals; Cell Line; Drug Interactions; Female; Humans; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds; Semustine | 1982 |
Effect of combined misonidazole and d(50)-Be neutrons on a human melanoma transplanted into nude mice.
Topics: Animals; Cell Line; Cell Survival; DNA Repair; Fast Neutrons; Half-Life; Humans; Injections, Intraperitoneal; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Neutrons; Nitroimidazoles; Radiotherapy Dosage; Time Factors; Transplantation, Heterologous | 1980 |
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Hypoxia; Cell Line; Chemical Phenomena; Chemistry, Physical; Cricetinae; Cricetulus; Heterocyclic Compounds; Humans; Mammary Neoplasms, Experimental; Melanoma; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Solubility; Structure-Activity Relationship; Water | 1995 |
Relationship between intracellular concentration and radiosensitizing effect of pimonidazole and etanidazole on two human melanoma cell lines.
Topics: Etanidazole; Humans; In Vitro Techniques; Melanoma; Nitroimidazoles; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1993 |
Relationship between the melanin content of a human melanoma cell line and its radiosensitivity and uptake of pimonidazole.
Topics: Animals; Autoradiography; Cell Line; Etanidazole; Humans; Melanins; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1993 |
Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.
Topics: Animals; Cell Hypoxia; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Melanoma; Mice; Mice, Inbred BALB C; Nitroimidazoles; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Transplantation, Heterologous; Tumor Cells, Cultured; Up-Regulation | 2002 |
Influence of tumour size on radiosensitization by misonidazole.
Topics: Animals; Cell Survival; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1978 |
Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
Topics: Animals; Gamma Rays; Humans; Male; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiotherapy Dosage; Time Factors; Transplantation, Heterologous | 1979 |
Influence of misonidazole on the radiosensitivity of a human melanoma in nude mice: time-dependent increase in surviving fraction.
Topics: Animals; Cell Survival; Female; Humans; Hypoxia; In Vitro Techniques; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1979 |
The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
Topics: Animals; Humans; Melanoma; Metronidazole; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation Dosage; Radiation-Sensitizing Agents; Time Factors | 1978 |
Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Topics: Adenocarcinoma; Animals; Cell Survival; Drug Synergism; Etanidazole; Female; Humans; Melanoma; Mice; Mice, Nude; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rectal Neoplasms | 1991 |
Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hypoxia; Lymph Nodes; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nitroimidazoles; Palliative Care; Radiation Tolerance; Radiation-Sensitizing Agents; Skin Neoplasms | 1987 |
The uptake of the radiosensitizing compound Ro 03-8799 (Pimonidazole) in human tumors.
Topics: Breast Neoplasms; Female; Humans; Melanoma; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Rectal Neoplasms; Uterine Cervical Neoplasms | 1989 |
Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Topics: Amifostine; Animals; Etanidazole; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1988 |
A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.
Topics: Adenocarcinoma; Drug Combinations; Drug Evaluation; Etanidazole; Humans; Melanoma; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |
A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
Topics: Adult; Aged; Animals; Carcinoma, Squamous Cell; Cricetinae; Cricetulus; Female; Humans; Male; Melanoma; Mice; Middle Aged; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1986 |
A phase II study of CCNU with benznidazole for metastatic malignant melanoma.
Topics: Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Lomustine; Melanoma; Nitroimidazoles | 1986 |